| Adjuvant Topical Sirolimus for Pulsed Dye Laser in Pediatric Capillary Malformation Y Gu, DF Sebaratnam Dermatologic Surgery 50 (3), 300-301, 2024 | 3 | 2024 |
| Dermatological considerations for transgender and gender diverse patients: An Australian perspective Y Gu, GT Tang, ASZ Cheung, DF Sebaratnam Australasian Journal of Dermatology 65 (1), 24-36, 2024 | 2 | 2024 |
| Contextualising associations of SJS/TEN with COVID-19 and the vaccine Y Gu, DF Sebaratnam Burns: journal of the International Society for Burn Injuries 49 (7), 1776-1777, 2023 | 2 | 2023 |
| GLP‐1 receptor agonists for hidradenitis suppurativa: Navigating benefits, risks, and ethical considerations Y Gu, DF Sebaratnam International Journal of Dermatology 63 (5), e100-e101, 2024 | 1 | 2024 |
| Biologics for inherited disorders of keratinisation: A systematic review MKY Chen, AL Flanagan, DF Sebaratnam, Y Gu Australasian Journal of Dermatology 65 (2), 185-214, 2024 | 1 | 2024 |
| Topical rapamycin and microcystic lymphatic malformations Y Gu, DF Sebaratnam Journal of the American Academy of Dermatology 90 (1), e29-e30, 2024 | 1 | 2024 |
| Multidisciplinary care of skin cancer in transplant recipients Y Gu, MM Polcz, DF Sebaratnam Internal Medicine Journal 53 (12), 2355-2356, 2023 | 1 | 2023 |
| Avoiding severe drug hypersensitivity reactions: a case for HLA genotyping for at‐risk patients HY Sun, Y Gu, DF Sebaratnam The Medical Journal of Australia 219 (6), 285-285, 2023 | 1 | 2023 |
| Towards precision medicine in vascular anomalies: Could protein kinase C inhibitors be repurposed for GNAQ/11‐related phakomatoses? Y Gu, JP Pham, DF Sebaratnam Skin Research and Technology 30 (6), 2024 | | 2024 |
| Economic Evaluation of HLA-B* 15: 02 Genotyping for Asian Australian Patients With Epilepsy Y Gu, STF Shih, N Geevasinga, L Chan, JW Frew, DF Sebaratnam JAMA dermatology, 2024 | | 2024 |
| Economic evaluation of HLA-B* 15: 02 genotyping in Asian Australian epilepsy patients Y Gu, S Shih, N Geevasinga, L Chan, J Frew, D Sebaratnam Clinical Medicine 24, 100131, 2024 | | 2024 |
| Pembrolizumab‐induced acquired perforating dermatosis Y Gu, D De Silva, CJA Henderson, DF Sebaratnam JEADV Clinical Practice, 2024 | | 2024 |
| Eccrine angiomatous hamartoma treated with multimodal vascular laser and incobotulinum Y Gu, K Truong, S Kossard, A Lim, DF Sebaratnam Skin Health and Disease, e434, 2024 | | 2024 |
| Sonography of focal facial dermal dysplasia Y Gu, DF Sebaratnam Sonography, 2024 | | 2024 |
| Arcanobacterium haemolyticum—Infection in an Immunocompetent Child Y Gu, G Millan, DF Sebaratnam The Pediatric Infectious Disease Journal 43 (1), e28-e29, 2024 | | 2024 |
| A Systematic Review of Laser Treatment for Angiofibromas in Tuberous Sclerosis Y Gu, MJ Verheyden, DF Sebaratnam, RC Liu Dermatologic Surgery, 10.1097, 2022 | | 2022 |
